Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies. [electronic resource]
Producer: 20100621Description: 467-73 p. digitalISSN:- 1873-3441
- Animals
- Antineoplastic Agents -- administration & dosage
- Cell Culture Techniques
- Cell Line, Tumor
- Cell Survival -- drug effects
- Doxorubicin -- administration & dosage
- Drug Carriers -- chemistry
- Drug Combinations
- Drug Compounding
- Drug Delivery Systems
- Endothelial Cells -- drug effects
- Flow Cytometry
- Humans
- Liposomes
- Male
- Melanoma, Experimental -- drug therapy
- Mice
- Mice, Inbred C57BL
- Oligopeptides -- chemistry
- Stilbenes -- administration & dosage
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.